Johnson & Johnson Innovation (JJI) has formed a new collaboration with Texas Medical Center (TMC) to accelerate the development of breakthrough medical device technologies.
Medical Device Entrepreneur Billy Cohn will lead JJI's new center for device innovation (CDI @ TMC), which expands the company's collaboration with TMC established earlier this year.
Cohn will work on internal research and development projects for the Johnson & Johnson Medical Devices Companies. He will also work with external entrepreneurs and innovators.
The new center will feature multiple components that will enhance the development of new medical technologies from concept through commercialization, including a new medical device engineering studio housed at the TMC Innovation Institute.
It will be used to accelerate both select internal projects and strategically aligned ventures of JJI partner companies.
The series of collaborative agreements will provide CDI @ TMC with access to the preclinical facilities of Baylor College of Medicine, Houston Methodist Research Institute, and THI to test novel devices for any organ system or disease-based application.
Johnson & Johnson chief scientific officer Paul Stoffels said: "By creating a nexus for innovation, where scientists and engineers of the Johnson & Johnson Family of Companies can collaborate with academicians, expert clinicians, and external entrepreneurs to leverage the unique size, scope, and capabilities of TMC's member institutions, we are confident that we can dramatically enhance health care around the world.”
TMC president and CEO Robert Robbins said: "Working together, we are creating a globally competitive innovation ecosystem here, and the new Center for Device Innovation @ TMC will enable us to expeditiously bring discovery and innovation to fruition, directly improving the health of patients."